A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range

Clinical trial NCT06041217 · COMPLETED

Trial details

NCT number: NCT06041217
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Overweight Obesity

Start date: 2023-09-15
Primary completion: 2025-04-02
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.